So…you misspoke?

I also find this a really odd line to draw. The fact that treating ICU patients with anticoagulants is standard does not automatically mean it’s useful for long COVID patients. If it turns out that it’s useful, awesome, but it’s not obvious a priori.

I didn't see them misspeak. They just clarified. Their follow up statement was right in line with their original.

Pretty cool that they're ahead of the curve on this.

Even if they didn't know about long covid officially, they followed the known science up to that point, and this is incompletely but interesting new data that's showing it's helping more than possibly known at the time.

They’re not ahead of the curve. This long COVID treatment experiment is new and they equated it with an entirely different treatment. Saying “we knew this 2 weeks in” is dismissive and absurd. Knowing that NIH recommends anticoagulants for acute hospitalized COVID is entirely different than knowing that anticoagulants are useful for treating long COVID.

If someone published a study that CTE resolves with a month of Tylenol supplementation, this would be huge news. The fact that acute concussion pain is treated with Tylenol in no way implies this result.

They stated they knew from the scientific literature that anticoagulants were beneficial so I'm assuming they werent referring to long covid but to just general efficacy against covid, because long covid hadn't been discovered yet.

In that sense they were ahead of the curve because its looking like it is helpful with long covid as well, which is great news!